The results showed that the cell activity of HepG2 and Bel7402 decreased gradually with the increasing concentration of inhibitor drugs (Figure 5D), indicating that inhibition of the LPL/FABP4/CPT1 axis could retard the proliferation of HCC cells. The gene discussed is LPL; the disease is hepatocellular carcinoma.